High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy. [electronic resource]
Producer: 20121204Description: 88 p. digitalISSN:- 1748-717X
- Antineoplastic Agents -- administration & dosage
- Anus Neoplasms -- metabolism
- Chemoradiotherapy
- Female
- Fluorouracil -- administration & dosage
- Humans
- Immunohistochemistry
- Inhibitor of Apoptosis Proteins -- biosynthesis
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Mitomycin -- administration & dosage
- Neoplasm Staging
- Risk Factors
- Survivin
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.